| 49138-1 |
California encephalitis virus Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
California encephalitis virus IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49138-1 |
|
IF |
|
|
Both |
|
|
|
0 |
CEV IgG Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA; Calif; Cerebral spinal fluid; Cerebrospinal Fl; CEV; CEV Ab; CEV IgG; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
This term has been undeprecated because upon further review, we confirmed that California encephalitis virus is a distinct member of the CAL serogroup in addition to LaCrosse virus (LACV), Jamestown Canyon virus (JCV), Snowshoe Hare virus, and Trivitattus virus. |
0 |
| 49139-9 |
California encephalitis virus Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
IF |
|
ACTIVE |
California encephalitis virus IgM Ab [Titer] in Cerebral spinal fluid by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49139-9 |
|
IF |
|
|
Both |
|
|
|
0 |
CEV IgM Titr CSF IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA; Calif; Cerebral spinal fluid; Cerebrospinal Fl; CEV; CEV Ab; CEV IgM; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
This term has been undeprecated because upon further review, we confirmed that California encephalitis virus is a distinct member of the CAL serogroup in addition to LaCrosse virus (LACV), Jamestown Canyon virus (JCV), Snowshoe Hare virus, and Trivitattus virus. |
0 |
| 4914-8 |
HLA-Dw7 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-Dw7 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4914-8 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-Dw7 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49140-7 |
California encephalitis virus Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
California encephalitis virus IgG Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49140-7 |
|
IF |
|
|
Both |
|
|
|
0 |
CEV IgG Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA; Calif; CEV; CEV Ab; CEV IgG; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin G; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
This term has been undeprecated because upon further review, we confirmed that California encephalitis virus is a distinct member of the CAL serogroup in addition to LaCrosse virus (LACV), Jamestown Canyon virus (JCV), Snowshoe Hare virus, and Trivitattus virus. |
0 |
| 49141-5 |
California encephalitis virus Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
IF |
|
ACTIVE |
California encephalitis virus IgM Ab [Titer] in Serum by Immunofluorescence |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49141-5 |
|
IF |
|
|
Both |
|
|
|
0 |
CEV IgM Titr Ser IF |
|
|
|
N |
|
ABS; Aby; ACIF; Antby; Anti; Antibodies; Antibody; Anticomplement Immunofluorescence; Autoantibodies; Autoantibody; CA; Calif; CEV; CEV Ab; CEV IgM; Dilution factor; Dilution Factor (Titer); Enc; Enceph; Encephalomyelitis; FA; Fluorescent antibody; Fluoresent; ID; IFA; Immune fluorescence; Immune globulin M; Immunoflour; Immunofluor; Immunofluorescence; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Time Resolved Fluorescence; Titer; Titered; Titre; TRF; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
This term has been undeprecated because upon further review, we confirmed that California encephalitis virus is a distinct member of the CAL serogroup in addition to LaCrosse virus (LACV), Jamestown Canyon virus (JCV), Snowshoe Hare virus, and Trivitattus virus. |
0 |
| 49142-3 |
La Crosse virus Ab.IgG & IgM |
Imp |
Ser |
Pt |
Nom |
|
|
ACTIVE |
La Crosse virus IgG and IgM [Interpretation] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49142-3 |
|
|
|
|
Observation |
|
|
|
0 |
LACV IgG+IgM Ser-Imp |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; California Encephalitis Virus; ID; IgG+IgM; Immune globulin G; Immune globulin M; Immunoglobulin G; Immunoglobulin M; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Lacrosse virus; LACV; Microbiology; Nominal; Point in time; Random; Serum; SR |
2.73 |
2.21 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 49143-1 |
North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
North American Association of Central Cancer Registries, Inc (NAACCR, Inc) Pathology Laboratory Electronic Reporting panel |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.TUMRRGT |
|
49143-1 |
|
|
|
|
Order |
|
|
|
0 |
NAACCR Path Lab Electronic Reporting Pnl |
|
|
|
N |
|
NAACCR Path Lab Electronic Reporting Pnl; North American Association of Central Cancer Registries; Pan; Panl; Path; Pnl; Point in time; Random; TUMOR REGISTRY(NAACCR) |
2.27 |
2.21 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 49144-9 |
Saint Louis encephalitis virus Ab.IgM |
PrThr |
Body fld |
Pt |
Ord |
|
|
ACTIVE |
Saint Louis encephalitis virus IgM Ab [Presence] in Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
49144-9 |
|
|
|
|
Both |
|
|
|
0 |
SLEV IgM Fld Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Enc; Enceph; Encephalomyelitis; Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SLE virus; SLEV; St Louis |
2.56 |
2.21 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49145-6 |
Rickettsia rickettsii Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia rickettsii IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49145-6 |
|
|
|
|
Both |
|
|
|
0 |
R rickettsi IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R rickettsi; R rickettsii; Random; Ricket; Rickettsial; RMSF; Rocky mountain spotted fever; SmQn; Spotted fever; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49146-4 |
Rickettsia rickettsii Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia rickettsii IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49146-4 |
|
|
|
|
Both |
|
|
|
0 |
R rickettsi IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R rickettsi; R rickettsii; Random; Ricket; Rickettsial; RMSF; Rocky mountain spotted fever; SmQn; Spotted fever; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49147-2 |
Rickettsia prowazekii Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia prowazekii IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49147-2 |
|
|
|
|
Both |
|
|
|
0 |
R prowazek IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Brill-zinsser disease; Dilution factor; Dilution Factor (Titer); Epidemic typhus; Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R prowazek; R prowazekii; Random; Recrudescent typhus; Ricket; Rickettsial; SmQn; Sporadic typhus; Titer; Titered; Titre; Ttr; Typhus |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49148-0 |
Rickettsia prowazekii Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia prowazekii IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49148-0 |
|
|
|
|
Both |
|
|
|
0 |
R prowazek IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Brill-zinsser disease; Dilution factor; Dilution Factor (Titer); Epidemic typhus; Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R prowazek; R prowazekii; Random; Recrudescent typhus; Ricket; Rickettsial; SmQn; Sporadic typhus; Titer; Titered; Titre; Ttr; Typhus |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49149-8 |
Rickettsia parkeri Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia parkeri IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49149-8 |
|
|
|
|
Both |
|
|
|
0 |
R parkeri IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R parkeri; Random; Ricket; Rickettsial; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 4915-5 |
HLA-Dw7 |
PrThr |
Bld/Tiss |
Pt |
Ord |
|
|
ACTIVE |
HLA-Dw7 [Presence] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4915-5 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-Dw7 Ql |
|
|
|
|
|
Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 49150-6 |
Rickettsia parkeri Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia parkeri IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49150-6 |
|
|
|
|
Both |
|
|
|
0 |
R parkeri IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R parkeri; Random; Ricket; Rickettsial; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49151-4 |
Rickettsia parkeri Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia parkeri IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49151-4 |
|
|
|
|
Both |
|
|
|
0 |
R parkeri IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R parkeri; Random; Ricket; Rickettsial; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49152-2 |
Rickettsia parkeri Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia parkeri IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49152-2 |
|
|
|
|
Both |
|
|
|
0 |
R parkeri IgM Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R parkeri; Random; Ricket; Rickettsial; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49153-0 |
Rickettsia conorii Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia conorii IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49153-0 |
|
|
|
|
Both |
|
|
|
0 |
R conorii IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Boutonneuse fever; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Mediterranean spotted fever; Microbiology; Point in time; R conorii; Random; Ricket; Rickettsial; SmQn; Spotted fever; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49154-8 |
Rickettsia conorii Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia conorii IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49154-8 |
|
|
|
|
Both |
|
|
|
0 |
R conorii IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Boutonneuse fever; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Mediterranean spotted fever; Microbiology; Point in time; R conorii; Random; Ricket; Rickettsial; SmQn; Spotted fever; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49155-5 |
Rickettsia akari Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia akari IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49155-5 |
|
|
|
|
Both |
|
|
|
0 |
R akari IgM Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R akari; Random; Ricket; Rickettsial; Rickettsial pox; Serum; SmQn; Spotted fever; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49156-3 |
Rickettsia akari Ab.IgM |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia akari IgM Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49156-3 |
|
|
|
|
Both |
|
|
|
0 |
R akari IgM Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R akari; Random; Ricket; Rickettsial; Rickettsial pox; SmQn; Spotted fever; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49157-1 |
Rickettsia akari Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia akari IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49157-1 |
|
|
|
|
Both |
|
|
|
0 |
R akari IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R akari; Random; Ricket; Rickettsial; Rickettsial pox; Serum; SmQn; Spotted fever; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49158-9 |
Rickettsia akari Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia akari IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49158-9 |
|
|
|
|
Both |
|
|
|
0 |
R akari IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R akari; Random; Ricket; Rickettsial; Rickettsial pox; SmQn; Spotted fever; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 49159-7 |
Rickettsia africae Ab.IgG |
Titr |
Body fld |
Pt |
SemiQn |
|
|
ACTIVE |
Rickettsia africae IgG Ab [Titer] in Body fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
49159-7 |
|
|
|
|
Both |
|
|
|
0 |
R africae IgG Titr Fld |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; R africae; Random; Ricket; Rickettsial; SmQn; Titer; Titered; Titre; Ttr |
2.75 |
2.21 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 4916-3 |
HLA-Dw8 |
PrThr |
Bld/Tiss^Donor |
Pt |
Ord |
|
|
ACTIVE |
HLA-Dw8 [Presence] in Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HLA |
|
4916-3 |
|
|
|
|
Observation |
|
|
|
0 |
HLA-Dw8 Donr Ql |
|
|
|
|
|
Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.56 |
1 |
|
|
|
|
|
|
|
|
|
|
This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
